Skip to content

Scientists in Singapore transform fruit leftovers into antibacterial bandages – Reuters

Sept 20 (Reuters) – Scientists at Nanyang Technological University (NTU) in Singapore are tackling food waste by turning discarded durian husks into antibacterial gel bandages.
The process extracts cellulose powder from the fruit's husks after they are sliced and freeze-dried, then mixes it with glycerol. This mixture becomes soft hydrogel, which is then cut into bandage strips.
"In Singapore, we consume about 12 million durians a year, so besides the flesh, we can't do much about the husk and the seeds and this cause environmental pollution," said Professor William Chen, director of the food science and technology programme at NTU. The fruit's husks, which make up more than half of the composition of durians, are usually discarded and incinerated, contributing to environmental waste.
Durian husk and petri dish containing cellulose hydrogel sheet made out of durian husk with yeast phenolics are seen in Singapore September 16, 2021. Picture taken September 16, 2021. REUTERS/Lee Ying Shan
Chen added that the technology can also turn other food waste, such as soy beans and spent grains, into hydrogel, helping limit the country's food waste.
Compared to conventional bandages, the organo-hydrogel bandages are also able to keep wound areas cooler and moist, which can help accelerate healing.
The researchers say using waste materials and yeast for the antimicrobial bandages is more cost effective than the production of conventional bandages, whose antimicrobial properties come from more expensive metallic compounds like silver or copper ions.
A durian wholeseller, Tan Eng Chuan, said he goes through at least 30 crates of durians a day during durian season – as much as 1,800 kg. Being able to use the parts of the fruit that are ordinarily discarded, he said, was an innovation that would make enjoying it "more sustainable".
Our Standards: The Thomson Reuters Trust Principles.
Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
An experimental antiviral pill developed by Merck & Co could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19, according to data that experts hailed as a potential breakthrough in how the virus is treated.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Information, analytics and exclusive news on financial markets – delivered in an intuitive desktop and mobile interface.
Access to real-time, reference, and non-real time data in the cloud to power your enterprise.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2021 Reuters. All rights reserved

source

답글 남기기

이메일 주소는 공개되지 않습니다. 필수 항목은 *(으)로 표시합니다